Preclinical CRO services in Greece.

We design and coordinate contract research in Thessaloniki, Greece. Our preclinical research services cover formulation and drug delivery, pharmacokinetics and biodistribution, efficacy in disease models, exploratory toxicology, and medical device and biomaterial evaluation.

A short, non-confidential summary is enough to start. Tell us what you are developing, its intended use, what evidence you already have, the decision you need to make and any deadlines.

Yes. We can help define what needs to be established, identify suitable models and outcomes, and turn the question into a study brief.

You can commission a stand-alone study, such as a candidate comparison or feasibility assessment. For a broader programme, we can organise studies around review points that determine what proceeds.

Yes. We review relevant reports and data summaries to see what the evidence already supports, which results can be compared and which gaps the new work should address.

We start with the intended use, mechanism, available evidence and the decision ahead. We select the simplest suitable model, assess its limitations and agree on outcomes that can answer the question.

Yes, where a cell-based approach can address the question. A focused feasibility study can help select a candidate, refine the next endpoint or clarify whether animal work is justified.

Yes. We agree on comparators and criteria for choosing what advances. The report explains the trade-offs, including when the results do not support a clear choice.

Where the study allows, we plan complementary assessments and interpret them together. If the questions call for different models or stages, we propose how to sequence the work.

The proposal sets out the study question, work plan, responsibilities, expected deliverables, timing and cost. It also identifies dependencies such as materials, facility availability and approvals.

Timing depends on model and facility availability, whether an assay is already suitable, when materials arrive and what approvals or analysis are needed. We identify the steps that affect the start date during scoping.

The estimate reflects the scope, number of candidates and endpoints, model, analytical work and reporting requirements. If key assumptions are still open, we can scope a feasibility phase or compare a focused option with a broader one.

We review how the proposed change affects the study question, deliverables, timing and budget with you before the additional work is agreed.

We identify the proposed facility and who will carry out each part of the work during scoping. If several teams or sites are involved, we define their roles and how we will review the results together.

We prepare the protocol and supporting documents, coordinate submission to the ethics committee for the facility where the study will be conducted, and handle follow-up and revisions. See ethics review and project authorisation for our planning estimate.

Tell us during the initial discussion. Before confirming the work, we identify the proposed test facility and verify the compliance scope applicable to that study.

Depending on the study, we may need test articles, comparators, material specifications and handling information. We agree on quantities, shipping and any documentation before materials are sent.

We agree on deliverables before the study. Depending on scope, these can include agreed datasets, analysis files or figures, and a report covering the results, limitations and recommended next steps.

Yes. Specify the files, formats or level of detail your team needs during scoping. We can also discuss practical arrangements for remaining samples and materials at that stage.

Yes. Start with a non-confidential summary. If more detail is needed, we can discuss a confidentiality agreement and how materials and information would be shared.

Bring up background IP, project-generated results, use rights and any publication plans while we scope the work. The applicable terms should be agreed in writing before work begins.

Yes. We can work from an existing dataset, a draft manuscript or a reviewer decision letter. Our scientific writing and publication support can cover the full manuscript and submission process or any individual stage.

We agree on progress updates and review points in the proposal. For phased work, interim results can inform whether the next stage should proceed or whether the plan needs to change.

We discuss what the data support, whether study limitations affected interpretation and what a repeat or revised study could clarify. We also identify when the results support stopping.

Yes. We can review the evidence with you, identify remaining gaps and prioritise follow-up work. If the data will support a formal submission, tell us early so the intended use and applicable requirements can shape the scope.

We can discuss a shared plan that defines who is responsible for each part of the study, how work is handed over and how results from different sites will be compared.